PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC

Code
APH-PGGP-01AX
Test
Active-Compendium
88360x1
Clinical
Oncology,Pathology
<b>Preferred specimen (FFPE block):</b><br>
A formalin-fixed, paraffin-embedded (FFPE) tissue block is the preferred specimen type. Use 10% NBF fixative; do not use zinc or mercury fixatives.<br>

<b>If submitting slides (instead of a block):</b><br>
Submit the following. All slides cut at 4-5 microns. Please use positively-charged slides and 10% NBF fixative.<br>
<span style="margin-left: 20px;">H&amp;E slide: One (1) unbaked, unstained slide for H&amp;E staining (required)</span><br>
<span style="margin-left: 20px;">Cut Slides: Two (2) positively charged unstained slides for each IHC test/antibody ordered</span><br>

<b>Specimen identification:</b><br>
Block and slide identifiers should be clearly written and match exactly with the specimen ID and specimen labeling as noted on the requisition.
Flag Active
True
Orderable Test Description
<p>PD-L1 IHC 28-8 pharmDx is a qualitative immunohistochemical assay using monoclonal rabbit anti-PD-L1, clone 28-8 intended for use in the detection of PD-L1 protein in formalin-fixed, paraffin-embedded (FFPE) gastric carcinoma, gastroesophageal junction carcinoma (GEJ) and esophageal adenocarcinoma (EAC) tissues using EnVision FLEX visualization system on Autostainer Link 48. Although PD-L1 testing has not received the FDA-approval for these tumor types, the CHECKMATE 649 Study showed that OPDIVO&reg; (nivolumab) in combination with chemotherapy demonstrated superior overall survival (OS) and progression-free survival (PFS) when compared to chemotherapy alone. Tissues with PD-L1 Combined Positive Score (CPS) 5 are considered to have PD-L1 expression. Stain-only (tech-only) testing is available to clients who have completed the test kit manufacturers online interpretation training. All PD-L1 IHC test options may be viewed here.</p>
Orderable Turn Around Time
1-2 Days
Meta Description
<p>PD-L1 28-8 (OPDIVO&reg;) for Gastric/GEJ/Esophageal Adenocarcinoma aids in identifying Gastric carcinoma, GEJ, and EAC patients for treatment with OPDIVO&reg; (nivolumab) and chemotherapy.</p>
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"Immunohistochemistry (IHC)": {"Expression": ["PD-L1"]}}
Keywords string
PDL1, gastric cancer, GC, gastroesophageal junction carcinoma, GEJ, esophageal adenocarcinoma, EAC, PD1, PD L1, PD-L1, CDx, cdx PD-L1 28-8 (OPDIVO®) for Gastric/GEJ/EAC
Title URL
pd-l1-28-8-opdivo-for-gastric-gej-eac
TAT Details

Global: 2 Days
Tech-Only (stain only): 24 Hours

Storage and transportation

Slides may be stored at room temperature; transport with cold pack, making sure cold pack is not in direct contact with specimen.
NYS Clients: Please provide Date and Time of Collection.